South Korea's Celltrion unit buys Eli Lilly's production facility for $330M

[Lilly Biotechnology Center in San Diego, California, USA.]
JHVEPhoto

* Celltrion's (OTCPK:CONI.F [https://seekingalpha.com/symbol/CONI.F]) U.S. subsidiary acquired Imclone Systems, a facility located in Branchburg, New Jersey, from Eli Lilly (NYSE:LLY [https://seekingalpha.com/symbol/LLY]) for $330M, according to a recent regulatory filing [https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20250923800076] in South Korea.
* The move is part of a strategic move to protect Celltrion's existing and future product offerings in the U.S. market from potential U.S. tariff risks by strengthening its manufacturing and supply chain presence within the country.
* The purchase covers the New Jersey plant itself, with Celltrion (OTCPK:CONI.F [https://seekingalpha.com/symbol/CONI.F]) indicating total initial investment, including operational costs, will be around $500M, and long-term expansion at the site could push total expenditure to at least $1B.
* The acquisition is expected to be completed by year-end.
* “The 1.4 trillion won investment (in the US plant) makes more economic sense than building a new plant in Korea,” Celltrion Group Chair and founder Seo Jung-jin commented.

MORE ON ELI LILLY, CELLTRION, INC.

* Eli Lilly: Orforglipron Sets Path Of Continued Revenue Growth In T2D And Obesity [https://seekingalpha.com/article/4824625-eli-lilly-orforglipron-sets-path-of-continued-revenue-growth-in-t2d-obesity]
* Eli Lilly: New Orforglipron Data In Focus As Commercial Business Outperforms [https://seekingalpha.com/article/4823781-eli-lilly-new-orforglipron-data-in-focus-as-commercial-business-outperforms]
* The GLP-1 Oral Frontier: Novo Nordisk And Eli Lilly's 100-Year Duel Enters Its Next Chapter [https://seekingalpha.com/article/4822066-the-glp-1-oral-frontier-novo-nordisk-and-eli-lillys-100-year-duel-enters-its-next-chapter]
* Insider trades: Nvidia, Tesla among notable names this week [https://seekingalpha.com/news/4496758-insider-trades-nvidia-tesla-among-notable-names-this-week]
* Trump considering website for consumers to buy discounted prescription drugs - report [https://seekingalpha.com/news/4496759-trump-considering-website-consumers-buy-discounted-prescription-drug]